MET and non-small cell lung carcinoma: SU11274 inhibits cell viability in c-Met-expressing non-small cell lung cancer (NSCLC) cells with IC50 values of 0.8–4.4 μM, and abrogates HGF-induced phosphorylation of c-Met and its downstream signaling [64, 67].